• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Sinovac Biotech Ltd. (SVA)

    -NasdaqGS
    4.90 Down 0.09(1.80%) 4:00PM EST
    Add to Portfolio
    Prev Close:4.99
    Open:4.98
    Bid:4.50 x 1000
    Ask:N/A
    1y Target Est:9.50
    Beta:0.15
    Next Earnings Date:N/A
    Day's Range:4.87 - 5.02
    52wk Range:4.51 - 8.14
    Volume:116,741
    Avg Vol (3m):136,034
    Market Cap:273.04M
    P/E (ttm):81.67
    EPS (ttm):0.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SVADown 1.80%273.04M
    GSKUp 2.97%104.07B
    SNYUp 1.81%122.84B

    Key Statistics

    Forward P/E (1 yr):54.44
    P/S (ttm):4.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.06
    Quarterly EPS Est (Dec-14) :0.01
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-6.78

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sinovac Biotech Ltd., a biopharmaceutical company, is engaged in the research, development, manufacture, and commercialization of vaccines for hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback